Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company MON. In the report, Morgan Stanley noted, “F2Q buy side expectations appear below consensus but largely inline with our own due to a weather timing shift into F3Q. A modest bump to both the low and the high end of guidance is likely, but we do not anticipate a material guidance upgrade until F3Q reporting when all of the seed is planted.” Monsanto Company closed on Wednesday at $111.72.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorReiterationAnalyst RatingsMorgan StanleyVincent Andrews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!